Medtech companies like BlueWind or Medtronic are increasingly investing in neuromodulation to treat urgency urinary ...

MSD has announced findings from the pivotal Phase III LITESPARK-022 trial, assessing the Keytruda-Welireg combination as adjuvant therapy for patients with clear cell RCC after nephrectomy.

Opus Genetics has reported early findings from its ongoing Phase I/II clinical trial of the OPGx-BEST1 gene therapy to treat ...

uniQure will run another trial of its Huntington’s Disease gene therapy following the FDA’s review. Credit: Vink Fan / Shutterstock.com uniQure’s stock has dropped by more than 40% after being asked ...

Faster and more cost-effective trials support early-stage research in China driving the country's drug discovery engine.

Ahead of Rare Disease Day, Abigail Beaney, editor of Clinical Trials Arena, spoke with Robert Barrie, editor of Pharmaceutical Technology and Frankie Fattorini, reporter for Pharmaceutical Technology ...

Synthekine has entered into a clinical trial partnership and supply agreement with MSD to investigate STK-012 in combination with Keytruda and chemotherapy in patients with first-line, PD-L1 negative ...

Mahzi Therapeutics has dosed the first patient in its Phase I/II UNITE study assessing MZ-1866, an investigational gene ...

For the global Phase III clinical programme, more than 6,000 people with type 2 diabetes were enrolled. Credit: megaflop / Shutterstock.com. Eli Lilly and Company has reported detailed findings from ...

The double-blind, placebo controlled trial enrolled 71 patients with SAD. Credit: Elena Kalinicheva / Shutterstock.com AtaiBeckley’s social anxiety disorder (SAD) drug has shown both safety and early ...

ViiV Healthcare has reported several successful HIV trials at CROI 2026, including its investigational candidates lotivibart, ...